Erasca Inc logo

Erasca Inc

ERAS
Healthcare|Biotechnology|USA
$18.53
-0.65 (-3.39%)
Tangible Book
$1.27

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, 0.33, 1.83, 33.24, 281.81 ], "ebit_estimate": [ -314.22, -203.05, -253.57, -286.46, -128.72 ], "ebitda_estimate": [ -316, -213.44, -246.16, -353.21, -68.54 ], "net_income_estimate": [ -297.84, -187.73, -226.95, -275.88, -121.72 ], "per_share_eps_estimate": [ -0.91, -0.57, -0.68, -0.78, -0.37 ], "eps_nri_estimate": [ -0.96, -0.56, -0.66, -0.78, -0.37 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.73, 2, 2.2, null, null ], "pretax_income_estimate": [ -297.84, -187.73, -226.95, -275.88, -119.79 ], "operating_cash_flow_per_share_estimate": [ -0.55, -0.32, null, null, null ], "roa_estimate": [ -70.1, -39, null, null, null ], "roe_estimate": [ -78.93, -33.03, -23.32, null, null ], "gross_margin_estimate": [ null, null, 99, 95, null ], "operating_cash_flow_estimate": [ -168.15, -97.84, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 23.49, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ null, null, null, null, null, null, null ], "ebit_estimate": [ -39.47, -41.88, -45.52, -46.03, -49.4, -52.8, -57.67 ], "ebitda_estimate": [ -39.48, -41.28, -42.7, -48.91, -51.43, -54.05, -61.55 ], "net_income_estimate": [ -35.36, -37.92, -41.78, -43.22, -46.89, -49.13, -53.82 ], "per_share_eps_estimate": [ -0.11, -0.12, -0.13, -0.14, -0.14, -0.15, -0.16 ], "eps_nri_estimate": [ -0.11, -0.12, -0.13, -0.13, -0.14, -0.14, -0.15 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -34.71, -37.09, -39.93, -43.22, -46.89, -49.13, -53.82 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 23.49, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-13 09:00:06
2026-07-13 08:00:05
2026-07-13 01:00:02
2026-07-11 03:00:03
2026-07-10 19:00:02
2026-07-09 22:00:06
2026-07-09 15:00:06
2026-07-09 14:00:07
2026-07-09 11:00:03
2026-07-08 15:00:04
2026-07-08 01:00:04
2026-07-07 23:00:04
2026-07-07 20:00:04
2026-07-07 10:00:03
2026-07-07 09:00:04
2026-07-04 03:00:03
2026-07-02 22:00:04
2026-07-02 14:00:05
2026-07-02 03:00:02
2026-07-01 15:00:26